Criteo S.A. (CRTO)
Over the next 13 weeks, Criteo S.A. has on average historically fallen by 12.2% based on the past 3 years of stock performance.
Criteo S.A. has fallen lower by an average 12.2% in 3 of those 3 years over the subsequent 13 week period,corresponding to a historical probability of 100%
The holding period that leads to the greatest annualized return for Criteo S.A., based on historical prices, is 6 weeks. Should Criteo S.A. stock move in the future similarly to its average historical movement over this duration, an annualized return of 44% could result.
Loxo Oncology, Inc. (LOXO)
Over the next 13 weeks, Loxo Oncology, Inc. has on average historically risen by 20.8% based on the past 2 years of stock performance.
Loxo Oncology, Inc. has risen higher by an average 20.8% in 1 of those 2 years over the subsequent 13 week period,corresponding to a historical probability of 50%
The holding period that leads to the greatest annualized return for Loxo Oncology, Inc., based on historical prices, is 4 weeks. Should Loxo Oncology, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 368% could result.
Puma Biotechnology, Inc. (PBYI)
Over the next 13 weeks, Puma Biotechnology, Inc. has on average historically risen by 52.4% based on the past 5 years of stock performance.
Puma Biotechnology, Inc. has risen higher by an average 52.4% in 4 of those 5 years over the subsequent 13 week period,corresponding to a historical probability of 80%
The holding period that leads to the greatest annualized return for Puma Biotechnology, Inc., based on historical prices, is 1 week. Should Puma Biotechnology, Inc. stock move in the future similarly to its average historical movement over this duration, an annualized return of 264% could result.